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1. Introduction
CD4 T lymphocytes can be subdivided into two groups 
based on the cytokine profiles they produce. Upon an-
tigen encounter in the presence of IL-12 and IFN-γ, na-
ive CD4 cells can differentiate into T helper 1 (Th1) cells 
that are characterized by the production of IFN-γ, IL-2 
and TNF-α. Alternatively, antigen signaling in the pres-
ence of IL-4 induces the naive CD4 cell population to de-
velop into Th2 effectors secreting IL-4, IL-5 and IL-13 [1]. 
Examples of Th2-associated responses include extracellu-
lar parasitic infections such as Schistosoma and Nippostron-
gylus and allergic and atopic diseases [2]. Viral infections 
are known to predominantly induce Th1 or Type 1 im-
munity that promotes the activation of CD8 T cells and 
macrophage functions and drives B cell differentiation. 
Type 1 responses are also prevalent in some autoimmune 
disorders [2] and are a hallmark of effective anti-tumor 
responses [3]. Understanding the role of CD4 cells in var-
ious immune responses is paramount for designing effec-
tive therapies for malignancy and autoimmunity and for 
formulating better vaccines that promote cell-mediated 
immunity to infection. This review will focus on the im-
portance of CD4 cells in a localized respiratory tract in-
fection, influenza. Special emphasis is given to the com-
parison of the CD4 response to influenza in the lung with 
the response to systemic and persistent infections such as 
LCMV and murine gammaherpesvirus, respectively.
Several factors contribute to the immune response to 
viral infection including the nature of the pathogen it-
self, the route of infection, whether it is a chronic per-
sisting, or acute infection and how the virus is presented 
to specific T cells for the adaptive response. Viruses are 
obligate intracellular parasites that replicate using host 
transcriptional and translational machinery. Influenza A 
viruses and the parainfluenza Sendai virus are negative 
strand RNA viruses that have limited infectivity due 
to the anatomical restriction of an enzyme necessary to 
cleave the viral surface proteins [4]. As such, replication 
is limited to the epithelial layer of the respiratory tract 
where, during the lytic phase of the virus life cycle, it 
causes tissue destruction. In contrast, lymphocytic cho-
riomeningitis virus (LCMV) is considered a non-lytic 
RNA virus that can replicate in the host without caus-
ing major damage. Infection of mice with LCMV via tail 
vein injection induces a systemic infection with high vi-
ral titers in spleen and liver that is eventually resolved 
by the host immune response [5]. In situations where 
the host response is suppressed, LCMV infection can be-
come more persistent with high viral titers but little tis-
sue destruction [5]. Finally, some viruses such as herpe-
seviruses (EBV) and retroviruses (HIV) are cytopathic 
viruses that cause an initial lytic infection followed by a 
latent persistent infection [4].
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Abstract
Immune responses to viral infections involve a complex orchestration between innate signals and adaptive responses of specific T 
and B cells. Anti-viral CD4 cells can direct CD8 responses by secreting a Type 1 panel of cytokines including IFN-γ, IL-2 and TNF-
α and can drive B cell production of IgG2a to neutralize infective viral particles. This review will focus specifically on the role of 
CD4 cells in the immune response to influenza, an acute, localized respiratory viral infection. We suggest that CD4 cells act as di-
rect effectors in protection against influenza, may contribute to immunopathology and generate functionally distinct memory 
subsets.
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2. Complexity of the adaptive immune response to 
influenza
Intranasal administration of influenza virus infects ep-
ithelial cells of the airways and is localized and con-
fined to the respiratory tract. Infection with sublethal 
doses of virus results in an acute infection since nor-
mal mice mount a vigorous immune response that lim-
its viral spread and promotes complete clearance from 
the lung within 7–10 days. Cytotoxic CD8 T cells play 
a major role in the clearance of influenza virus from the 
lungs via a class-I-dependent cytotoxic mechanism in-
volving perforin and Fas [6]. Early work using class-I-
deficient mice (β2 microglobulin−/−), which lack CD8 
cells, suggested that viral clearance of HKx31 influenza 
in the respiratory tract was delayed [7]. In mice infected 
with a highly pathogenic strain of influenza, A/Puerto 
Rico/8/34 (PR8), a lack of CD8 cells led to increased vi-
ral replication and eventual morbidity [8]. This latter re-
sult would seem to indicate that CD8 cells were abso-
lutely required for viral clearance.
It has also been demonstrated that B cells and neutral-
izing antibodies can play an important role in immunity 
to influenza. B cell-deficient μMT mice could clear HKx31 
influenza with slightly delayed kinetics and normal CTL 
responses [9]. However, clearance of PR8 influenza was 
compromised in μMT mice and this led to increased mor-
bidity compared to that of wildtype controls [10]. Thus, 
the relative requirements for CD8 cells versus B cells in 
the clearance of influenza may depend upon the pathoge-
nicity and virulence of different strains [11, 12].
3. Requirement for CD4 cells in anti-viral responses
To investigate whether CD4 cells were absolutely re-
quired for clearance of virus, early work made use of de-
pleting antibodies to CD4 [13] or gene targeted mice de-
ficient in class II molecules [14, 15]. In anti-CD4 antibody 
treated mice, there was no difference in the CTL precur-
sor frequency in the draining LN or the BAL in response 
to HKx31 infection [13]. Moreover, mice deficient in MHC 
class II molecules and thus devoid of most CD4 cells, 
demonstrated similar CTL activity compared to wild type 
mice and only a slight delay in viral clearance from the 
lungs [14]. In another report, the precursor CTL frequen-
cies were four- to six-fold lower in class II−/− mice than in 
wild type counterparts; however, the lytic ability of CTL 
effectors at the peak of the anti-viral response was equiv-
alent between CD4-deficient and wildtype mice [15]. It 
should also be noted that IL-2 and IFN-γ, as well as IL-4 
and IL-5 production in the draining LN and BAL of CD4-
deficient mice was greatly reduced, suggesting that CD4 
cells contribute to the immune response at the site of in-
fection by the secretion of cytokines [15].
CD4-depleted mice could effectively clear PR8 virus, 
implying that CD4 cells were not required for elimina-
tion of virulent influenza strains [16]. However, the role 
of CD4 cells in response to influenza becomes more ap-
parent when B cells and T helper cells are absent. μMT 
mice treated with anti-CD4 depleting antibodies can-
not clear PR8 virus and show a high mortality to this 
virulent strain [16]. This suggests that CD8 cells alone 
cannot clear virus and indicates that CD4 cells may be 
important in helping to sustain the cytotoxic T cell re-
sponse. In a similar set of experiments, using B cell-de-
ficient mice treated with anti-CD8 depleting antibod-
ies, the remaining CD4 response alone was ineffective at 
clearing virus and mice succumbed to an otherwise sub-
lethal dose of HKx31 [17] or PR8 [10]. These data indi-
cated that CD4 cells alone could not effectively clear vi-
rus and suggested that their main purpose in anti-viral 
immunity may be to provide help for antibody produc-
tion [10, 17]. Therefore, the results from cell depletion 
studies indicated that CD4 cells may only participate in-
directly to provide help for CD8 and B cells.
Table 1, adapted from Gerhard [12], indicates that 
for a virulent strain of influenza, neither CD8 cells, CD4 
cells, or B cells alone can effectively clear virus and mice 
succumb to what would otherwise be a sublethal dose 
of virus. However, if combinations of cells are present, 
mice can clear infection with slightly delayed kinetics 
and increased survival. Therefore, the immune response 
to pathogenic strains of influenza requires a complex in-
terplay between cytotoxic T cells, antibody secreting B 
cells and cytokine secreting CD4 cells.
A role for CD4 T cells is also observed in CD8 re-
sponses to LCMV. During acute LCMV infection, CD8 
cytotoxic cells are required as mice deficient in CD8 cells 
cannot effectively clear virus [18]. However, the CD8 re-
sponse appears in part to rely on CD4 cells since CD4-
deficient mice demonstrated delayed viral clearance and 
a decline in CTL activity late in the primary response 
and into the secondary response [18]. Furthermore, CTL 
activity and CD8 memory responses were impaired in 
class-II-deficient mice leading to a recrudescence of vire-
mia 2 months after initial infection [19]. Thus, in the pri-
mary response to both localized and systemic infections, 
Table 1. Adapted from Gerhard, demonstrating the complex-
ity of the immune response to virulent strains of influenza.
 CD8            CD4            B cells   Clearance (days)    Survival (%)
 +  +  +  7–10  100
 –  +  +  10–14  100
 –  +  –  >20  0
 –  –  +  >20  0
 + –  –  >14  20
 + +  –  10–14  35–85
 + –  +  10–14  90
 – –  – >20  0
Each cell type of the adaptive immune response was depleted 
via treatment with antibody, using genetically altered mice, or 
a combination of both. As shown in rows 3, 4 and 5 neither 
CD8, CD4 nor B cells alone can effectively clear virus or pro-
mote survival of mice given A/Puerto Rico/8/34.
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CD4 cells appear to be dispensible as long as CD8 cells 
and B cells are present. In contrast, CD4 cells are re-
quired in the immune response to such chronic infec-
tions as gamma herpesvirus [20] and chronic infection 
with LCMV [21]. Moreover, CD4 cells are important 
for the maintenance of CD8 cytolytic responses and the 
transition to the memory phase in both acute, localized 
infections such as influenza [22] and systemic LCMV in-
fections [19, 23].
4. Initiation of the response: DCs activate CD4 helper 
cells
Activation of naive CD4 cells requires antigen specific 
signaling through the T cell receptor (TCR) as well as sig-
naling through co-stimulatory molecules. It is likely that 
lymph nodes and perhaps spleen provide the spatial or-
ganization and appropriate chemokine environment to 
bring together professional APCs and naive CD4 cells 
during priming of an anti-viral immune response [24, 25]. 
Dendritic cells (DC) at the site of infection can engulf vi-
ral particles, mature in response to inflammatory signals, 
migrate to draining LN and present peptide antigen in 
the context of class II molecules to activate naive virus-
specific CD4 cells [26]. It has been well-documented that 
the skin contains a web of immature DC termed Langer-
hans cells that can migrate rapidly to draining LN in re-
sponse to a variety of inflammatory stimuli [27]. It has re-
cently been appreciated that the respiratory tract contains 
a similar network of resident DC that migrate to respira-
tory LN under steady state conditions [28, 29]. Using in-
tranasal administration of CFSE followed by influenza 
infection, it was shown that a high percentage of CD11c+/
CFSE+ cells accumulated in the draining LN that peaked 
18 h after infection [29]. Interestingly, DC accumulation 
declined quickly and the ability of these cells to migrate 
to an additional inflammatory stimulus was diminished 
[29]. This suggests that DC migration in response to in-
fluenza infection is transient and it remains to be deter-
mined if other cell types transport antigen to the draining 
LN after the initial wave of DC migration. In addition, it 
is not known what effect chronic infections may have on 
DC migration or if an immune response to a secondary 
infection is compromised due to the short-lived nature of 
the DC response.
5. Tracking anti-viral CD4 responses directly: 
techniques
Although CD4 cells themselves may not have a primary 
role in the clearance of acute viral infections, their role 
in maintaining CD8 T cell memory and B cell responses 
is well-established in many models [12, 30, 31]. Most of 
the early work quantitating the frequencies of anti-vi-
ral CD4 responses made use of limiting dilution analysis 
(LDA) and IFN-γ ELISPOT assays [4, 32]. Frequencies 
of influenza reactive CD4 cells were estimated by LDA 
analysis to be in the order of approximately 1 in 300 
in the spleen at the peak of the immune response [17]. 
This study did not analyze the response in the lung or 
the BAL, where the infection is localized and high num-
bers of CD4 cells are recruited [33, 34]. In a similar respi-
ratory infection, the frequencies of CD4 cells reactive to 
Sendai virus were enumerated and found to be equiva-
lent to those obtained in the influenza system [35]. Com-
parably, in response to a systemic infection with LCMV, 
the frequency of IFN-γ secreting CD4 cells was shown 
to be about 1 in 200 against virally infected targets and 1 
in 40 for the dominant class II peptide [36, 37]. In all vi-
ral infections that are resolved after an acute phase, the 
frequency of virus-specific CD4 cells drops to approx-
imately 1 in 500 to 1 in 1000 in the memory phase [9, 
35–37]. Conversely, during persistent infection with a 
murine gammaherpesvirus, CD4 cell frequencies were 
shown to remain high even after many months [38].
With the advent of new technologies, it is now possi-
ble to track virus-specific CD8 and CD4 cells directly us-
ing complexes of MHC class I or class II molecules loaded 
with specific peptides [39, 40]. With this technique, it is 
possible to quantitate CD4 responses directly without 
culturing cells and estimating precursor frequencies. It 
has been demonstrated that the dominant CD4 response 
to LCMV is directed toward a glycoprotein peptide 61–
80, but the frequency of cells reactive to this epitope has 
been underestimated using LDA and ELISPOT assays. 
While ELISPOT assays have estimated the frequency of 
CD4 cells reactive to GP61–80 to be approximately 1 in 40, 
multimer analysis has enumerated the dominant CD4 re-
sponse to be 1 in 9 [41]. Thus, multimers can detect cells 
that have expanded in response to infection; however, 
there may be a disparity between the number of antigen 
reactive cells and the number of terminally differentiated 
effector cells capable of secreting cytokines. Importantly, 
this technology has provided insight to the differences in 
expansion, contraction and memory generation between 
virus-specific CD8 and CD4 responses. For both LCMV 
[41] and Sendai infection [42], it has been observed that 
the CD8 expansion or burst size is greater than the CD4 
expansion phase. Virus-specific CD4 cells contract with 
different kinetics than CD8 cells and the frequency of 
CD4 cells detected in the memory pool is much lower (1 
in 500) than the frequency of CD8 cells (1 in 12) [41]. In 
our own experiments using adoptive transfer of TCR Tg 
CD8 and CD4 cells reactive to hemagglutinin peptides, 
we have found that CD8 numbers in the lung and BAL 
exceeded the numbers of CD4 cells at the site of infec-
tion, regardless of the input cell numbers (Powell, et al. 
manuscript submitted). The mechanisms regulating the 
numbers of CD8 and CD4 cells have yet to be elucidated, 
however, it has been suggested that differences in sur-
vival factors such as Bcl-2 could be responsible [41]. Al-
ternatively, cytokines that regulate homeostatic prolifer-
ation and survival such as IL-2, IL-7 and IL-15 may affect 
CD8 cells differently than CD4 cells [32, 43, 44].
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There exists to date various multimeric reagents to 
detect CD4 responses to LCMV [41], ovalbumin, pi-
geon cytochrome C [40], and mycobacterial antigens 
[45]; however, there seems to be a paucity of CD4 ep-
itopes defined for influenza. In BALB/c mice infected 
with PR8 virus, Gerhard and co-workers [46] have iden-
tified CD4 T cell clones that are reactive to purified ma-
trix, nucleoprotein, hemagglutinin and neuraminidase 
proteins. Using synthetic peptides, eight distinct epi-
topes were identified in the hemagglutinin protein of 
PR8 that were recognized by T cell clones [47]. T cell re-
ceptors from two of these clones have been used to gen-
erate TCR Tg mice that recognize either HA110–120 [48] or 
HA126–138 [49]. Despite the availability of some reagents, 
the low frequency of CD4 cells and low affinity of class 
II multimers for peptide makes detection of the primary 
response difficult without first priming in the presence 
of peptide and adjuvant [42].
To circumvent some of these difficulties, our laboratory 
employs an adoptive transfer system in which CD4 cells 
from TCR transgenic mice that recognize a peptide 126–
138 in the hemagglutinin (HA) protein of PR8 influenza 
virus [49] are transferred into Thy 1 disparate BALB/
c mice. After sublethal infection, CFSE labeled TCR Tg 
CD4 cells can be visualized for division and effector gen-
eration using four color flow cytometry with antibodies 
to CD4, Thy1 and various surface markers [34]. This al-
lows the characterization of the early events in CD4 cell 
proliferation and activation in response to infection that 
cannot be appreciated using tetramer or IFN-γ ELISPOTs 
due to the low frequency of the initial CD4 population.
6. Primary CD4 responses to influenza
HA-specific CD4 TCR Tg cells were adoptively trans-
ferred into normal BALB/c mice and subsequently chal-
lenged with a sublethal dose of PR8. Our data indicate 
that there was a vigorous CD4 T cell response to influ-
enza initiating in the draining LN followed by the spleen 
and peaking in the lung and bronchoalveolar lavage 
(BAL) at 6–7 days post-infection [34]. This response was 
dominated by a Th1 cytokine profile as IL-2 was made 
by Tg CD4 cells in the draining LN, but only IFN-γ and 
TNF-α was produced by terminally differentiated CD4 
effector cells in the lung and BAL. CD4 T cell prolifera-
tion was initiated in the draining mediastinal LN where 
cells in each round of cell division could be observed. 
Only the cells that had divided completely and had dif-
ferentiated to an effector cell (as defined by phenotype 
and cytokine secretion) could be found in the lung and 
BAL. It is not yet clear how the vigorous primary CD4 
response and the production of IFN-γ by recruited CD4 
effectors contributes to protection in the lung. Further-
more, it is not known how CD4 effectors contribute to 
the generation of protective memory at the site of infec-
tion and these questions are the focus of current efforts.
7. CD4 effector mechanisms and protection
The predominance of a Th1 response characterized by 
secretion of IFN-γ led to the investigation of this cyto-
kine in the immune response to influenza. Infection of 
mice with a targeted disruption of the IFN-γ gene dem-
onstrated increases in type 2 cytokine production and 
increases in influenza-specific IgG1 antibody secre-
tion [50]. However, cytotoxic T cell responses in these 
mice were comparable to wildtype controls. Interest-
ingly, CD4 cell clones isolated from IFN-γ−/− mice and 
restimulated in vitro could protect against lethal chal-
lenge with influenza via a cytolytic mechanism [50]. It 
has also been demonstrated that virally infected class-
I-deficient mice have CD4 cells capable of lysing Sendai 
or LCMV-infected targets [11], suggesting that CD4 cells 
can compensate for the lack of IFN-γ or CD8 cells by be-
coming killers themselves. The importance of cytolytic 
CD4 cells in the response to influenza remains contro-
versial since experiments using bone marrow chimeras 
with class II−/− epithelial cells demonstrated that CD4 
cells did not have to directly recognize infected epithe-
lium in order to exert effector function [11]. In contrast, 
CD4 cell clones isolated from wildtype [51] or IFN-γ-de-
ficient mice [50] could protect against a lethal inocula-
tion with influenza that depended not on their cytokine 
profile, but their ability to lyse virally infected targets.
We found that TCR Tg CD4 effectors specific for HA 
peptide that are recovered from the lung and BAL of in-
fected mice produce high amounts of IFN-γ ex vivo, but 
undetectable levels of Th2 cytokines such as IL-4 ([34] 
and Brown, unpublished observations). To further dissect 
the mechanism of CD4 mediated protection to lethal in-
fluenza infection we have utilized a monoclonal CD4 cell 
population from TCR Tg mice deficient in IFN-γ as well 
as polyclonal CD4 effectors from sublethally infected 
BALB/c IFN-γ−/− mice. Table 2 shows that protection me-
diated by in vivo generated, polyclonal CD4 effector cells 
was dependent on IFN-γ, however, protection mediated 
by unfractionated lung cells did not require IFN-γ. In a 
separate set of experiments, influenza-specific wildtype 
and IFN-γ-deficient TCR Tg CD4 cells were stimulated 
in vitro with HA peptide and Th1 polarizing cytokines. 
These monoclonal populations were then transferred i.v. 
to BALB/c mice that were then infected with a lethal dose 
of PR8 and monitored for survival (Table 2). Surprisingly, 
IFN-γ was not required for CD4-mediated protection by 
a monoclonal, in vitro stimulated population of effectors. 
Furthermore, both wild type and IFN-γ deficient in vi-
tro generated effectors were cytolytic suggesting an alter-
nate mechanism of protection in vivo ( Table 2). We sug-
gest that one possiblility to explain these findings is that 
in vivo generated effectors may not be cytolytic and are 
more dependent on IFN-γ for effector function, whereas 
in vitro generated effectors have compensated for the lack 
of IFN by acquiring high CTL activity. In a similar study, 
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it was demonstrated that Sendai-specific memory CD4 
cells isolated from BAL fluid and transferred to naive 
mice could reduce viral load after Sendai infection [52]. 
Therefore, virus-specific CD4 cells can confer protection 
in both intact (Brown, manuscript in preparation) [51] 
and β2m-deficient mice [52]. This strongly suggests that 
CD4 cells may exert direct protective effects in response 
to influenza. What is not known is whether these effec-
tors are directly cytolytic in vivo, or whether they recruit 
other host cells to the site of infection due to rapid expres-
sion of cytokines and chemokines, or confer protection by 
a combination of mechanisms.
The balance between viral clearance and tissue de-
struction may, in some cases lead to immunopathology. 
This has been demonstrated in the immune response to 
influenza, where CD8 effectors unable to secrete IFN-
γ caused more lung damage than Tc1 effectors capable 
of producing IFN-γ [53]. Similarly, CD8 cells in chronic 
LCMV infection were shown to induce wasting disease 
in IFN-γ-deficient, CD4-depleted mice [21]. This sug-
gests that IFN-γ secretion by CD8 cells exerts a protec-
tive effect during immune-mediated damage in the lung 
and other organs. Indeed, damage mediated by Tc1 IFN-
γ−/− and Tc2 IFN-γ−/− effectors included increases in eo-
sinophilia and necrotizing lesions [53]. It is not known 
to what extent CD4 cells contribute to lung immunopa-
thology after influenza infection, however, it is known 
that Th2 cells do not protect against lethal influenza in-
fection [51] and the reason for this may be due to in-
creased pathology mediated by the type 2 cytokines, 
IL-4 and IL-5 leading to eosinophilia. Recently, it has 
been shown that blocking the OX40-OX40L costimula-
tory pathway can lead to decreased T cell influx into the 
lungs and diminished immunopathology after influenza 
infection [54]. It remains to be determined if CD4 and 
CD8 cells contribute equally to immunopathology after 
infection with more virulent strains of influenza. Fur-
ther, it is not known where influenza-specific CD4 cells 
localize in the lung parenchyma and what other types of 
cells they contact within the lung. If the primary role of 
CD4 cells is to help promote the antibody response, then 
why do such large numbers of activated CD4 effectors 
traffic to the lung and BAL? Is this a consequence of in-
flammation and recruitment of cells due to their activa-
tion status alone, or is there evidence for CD4/CD8 and 
or CD4/B cell interactions within lung tissue?
8. Memory CD4 responses to influenza
It has been demonstrated, using multimers, that the con-
traction phase in the CD4 compartment is more pro-
nounced than in the CD8 population, leading to a de-
cline in CD4 cell numbers in the memory phase in 
LCMV [41] and Sendai infection [42]. Tracking CD4 cells 
into the memory phase after influenza infection has been 
technically difficult due to the low numbers of CD4 cells 
that persist into memory, and the availability of reagents 
to detect low frequencies of cells. In our studies using 
the adoptive transfer system, we have shown a similar 
pattern to what has been observed in LCMV and Sen-
dai infection. Specifically, influenza reactive CD4 cells 
demonstrate an increased contraction phase compared 
to influenza-specific CD8 cells at the site of infection, 
namely the lung parenchyma and the airways (Powell, 
et al., manuscript submitted; Roman, unpublished ob-
servations). In addition, the frequency of CD4 cells that 
persist into memory is lower than the frequency of CD8 
cells in non-lymphoid sites (lung and BAL). Interest-
ingly, the frequency of CD4 cells in the memory phase 
in the lymphoid sites (spleen and LN) more closely re-
semble the frequency of CD8 memory cells.
The primary CD4 response to influenza is comprised 
of a heterogeneous mix of effector populations in which 
the effector cells in the lung and BAL show a more ac-
tivated phenotype while CD4 effector cells remaining in 
the lymphoid organs are less differentiated and mainly 
Table 2. Protection mediated by in vivo generated CD4 effectors is dependent on IFN-γ
Isolation                                               Effectors                                       IFN-γ                          Survival                             Cytolytic  
                                                                                                                production                           (%)                                   activity
In vivo, total lung  Polyclonal WT  Yes  100  ND*
 Polyclonal IFN-γ-/-  No  100  ND
 None  –  20  –
In vivo, CD4 cells  Polyclonal WT  Yes  100  ND
 Polyclonal IFN-γ-/-  No  20  ND
 None  –  0  –
In vitro, Th1  TCR Tg WT  Yes  100  Yes (++)
 TCR Tg IFN-γ-/-  No  100  Yes (+++)
 None  –  0  –
Total lung cells or CD4 cells from lung and draining LN were isolated from wildtype BALB/c or IFN-γ-deficient BALB/c mice 7 
days after a sublethal infection with influenza PR8 (polyclonal WT or IFN-γ−/−). TCR Tg CD4 cells from wildtype or IFN-γ-defi-
cient mice were stimulated in vitro with B cell blasts and specific peptide in the presence of IL-2, IL-12 and anti-IL-4 (in vitro Th1). 
Cells were transferred to normal BALB/c mice that were subsequently infected with a 5LD50 dose of PR8 and monitored for sur-
vival. BALB/c mice that did not receive cells served as a control. Wildtype or IFN-γ-deficient Th1 effectors were tested for cyto-
lytic activity in an in vitro JAM assay using peptide pulsed A20 cells or unpulsed A20 as a negative control.
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produce IL-2 [34]. After viral clearance, effector cells rep-
resenting all stages of differentiation can give rise to cor-
responding heterogeneous memory populations. CD4 
memory cells detected in the LN and spleen demonstrate 
high levels of CD62L and CCR7 while CD4 memory cells 
detected in the lung more than 30 days post-infection are 
small resting cells that express low levels of CD62L and 
CCR7 and high CD43 (Roman, et al., in preparation). The 
generation of heterogeneous memory subsets in differ-
ent organs suggests that functional CD4 memory could 
be different based on distinct anatomical localization. The 
CD4 memory response to Sendai virus is also heteroge-
neous [42]. Phenotypic markers such as CD43 and CD11a 
are differentially expressed on tetramer positive cells in 
the lung parenchyma compared to the airways and tet+ 
cells in the lung demonstrate a highly activated pheno-
type compared to cells in the lymphoid organs [42]. Taken 
together, these data suggest that there are multiple, phe-
notypically diverse subsets of memory CD4 cells that are 
likely to function differently. In particular, CD4 memory 
subsets in the lung are poised for immediate response to 
reinfection in the respiratory tract while CD4 cells in the 
lymphoid organs may be recruited later in the response. 
An interesting aspect of these studies is that the decay of 
CD4 memory cells in the lungs is faster than in the pe-
riphery suggesting a temporal, as well as phenotypic dif-
ference in long lasting CD4 immunity to infection. This 
may have important implications for vaccine develop-
ment and the functions of CD4 memory subsets are cur-
rently being investigated in our laboratory.
9. Summary and concluding remarks
CD4 cells are an important component of the anti-viral 
response to local and systemic infections. Although early 
studies using CD4-depleted mice have suggested that 
CD4 cells were not absolutely required in the primary re-
sponse, more recent studies have determined that CD4 
cells were necessary for long lasting, effective CD8 mem-
ory. In addition, the primary CD4 T cell response to influ-
enza infection, albeit smaller in magnitude than the CD8 
response, was shown to involve robust expansion, Th1 
differentiation and migration to the site of infection. CD4 
effector cells can also promote survival to a lethal dose of 
influenza infection and may contribute to immune-me-
diated pathology. Finally, the heterogeneity in the CD4 
population observed in the primary response is recapit-
ulated in the memory phase after the infection has been 
cleared. Thus, we consider the possibility that CD4 effec-
tor T cells and memory contribute to immunity to influ-
enza via multiple mechanisms that are just beginning to 
be appreciated. These may include their classic contribu-
tion as helpers during the generation of flu-specific CD8 
CTL and antibody producing B cells; and also the possi-
bility that CD4 effectors in the lung may directly mediate 
viral clearance by IFN-γ-dependent mechanisms and/or 
by direct cytolytic effects on infected cells.
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